SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-003472
Filing Date
2021-01-13
Accepted
2021-01-13 19:07:09
Documents
1
Period of Report
2021-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4157
  Complete submission text file 0001209191-21-003472.txt   5709
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 30 ROCKEFELLER PLAZA, SUITE 5508 NEW YORK NY 10112
Business Address
Hove Anders D (Reporting) CIK: 0001365618 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 21527125